Bizotic Commercial to price warrants at Sep 30 meet

What the company told the exchange

Bizotic Commercial Ltd (BSE: 543926) informed the BSE that its Board of Directors will meet on Wednesday, September 30, 2026 at 2:00 PM at the company’s registered office. The board agenda includes finalising the issue price for a proposed issuance of convertible warrants through a preferential issue. The company also said the board will fix the day, date, time, and venue for an Extra-Ordinary General Meeting (EGM) and approve the EGM notice. Any other business may be taken up with the chairman’s permission.

Why this board meeting matters

The September 30 meeting is positioned as a follow-through to an earlier board decision on September 10, 2026. At that meeting, the board had already approved fundraising via convertible warrants on a preferential basis, subject to shareholder and other applicable approvals. The upcoming meeting is expected to settle a key missing element: the issue price, based on a draft valuation report obtained from a registered valuer entity. The pricing decision is central because it determines the amount of capital that can be raised and the eventual share issuance on conversion. It also sets the foundation for the shareholder approval process through an EGM.

Preferential warrants: what has already been approved

Bizotic Commercial’s board has approved raising funds through the issue of up to 1,36,08,000 convertible warrants. Each warrant is convertible into one equity share of the company with a face value of Rs. 10 each. The warrants are proposed to be issued to persons or entities in the “Promoter and Promoter Group” and “Non-Promoter Category” on a preferential basis. The company stated the issuance may be completed in one or more tranches and remains subject to necessary shareholder approvals and other applicable approvals.

Key conversion and payment terms disclosed

The disclosures also note that the warrants are convertible into equity shares within 18 months. The company stated that 25% is payable upfront, with the balance payable on conversion. These terms are typical of preferential warrant structures where part-payment is collected at allotment and the remainder at conversion. Because conversion results in equity shares, the transaction can change the company’s shareholding pattern and the number of shares outstanding.

Promoter and non-promoter participation details

Bizotic Commercial has disclosed expected ownership implications from the proposed allotments. The proposed allottees would hold 25.55% of the company after the issue, as stated in the company’s disclosure. It also specified that three promoter-group entities account for 1.0212 crore of the warrants. These details help investors understand where a significant portion of the proposed warrants are intended to be allocated.

What the board will decide on September 30

According to the intimation, the board will consider and approve the issue price for the proposed issuance of convertible warrants. The company linked this directly to the agenda approved at the board meeting held on September 10, 2026 and the draft valuation report from a registered valuer entity. Separately, the board will decide the EGM logistics and approve the EGM notice. The company has also indicated that the decision to hold the EGM and the relevant documents will be submitted “in due course.”

Bonus issue background: 5:1 allotment already completed

The company’s recent capital actions include a 5:1 bonus issue process that has moved into the allotment stage. Bizotic Commercial’s board approved the allotment of 4,82,10,000 fully paid-up bonus equity shares of Rs. 10 each in a 5:1 ratio at its meeting held on Tuesday, August 18, 2026. The record date for eligibility was Monday, August 17, 2026, and the deemed date of allotment was Tuesday, August 18, 2026. The company said the new bonus shares rank pari-passu with existing equity shares, carrying identical rights on dividends and other corporate benefits.

How the bonus issue changed the equity base

The disclosures provide a clear before-and-after view of Bizotic Commercial’s share capital. Before the bonus allotment, the company had 96,42,000 issued, subscribed, and paid-up equity shares. After the allotment, the total number of equity shares increased to 5,78,52,000. Correspondingly, the issued, subscribed, and paid-up equity share capital increased from Rs. 9,64,20,000 to Rs. 57,85,20,000, which the company also described as ₹57.85 crore (₹57.852 crore in one disclosure).

Authorised capital increase and AGM approvals

Bizotic Commercial also disclosed that its authorised share capital was increased to support the enlarged share count. One disclosure stated the authorised share capital was increased from ₹11.27 crore to ₹57.86 crore, linked to accommodating the bonus issue and future expansion needs. The company’s 10th AGM held on August 1, 2026 also included approvals related to the bonus issue and capital expansion, along with other corporate actions such as appointments, as disclosed by the company.

Summary table: key events and numbers

Market impact: what investors typically track from here

The immediate market relevance of the September 30 meeting is procedural but important: finalising warrant pricing and moving the proposal toward shareholder approval via an EGM. The issue price, once approved, will clarify the effective terms of the preferential issue that was approved in principle on September 10. Investors also tend to track how preferential warrants, if converted within the stated 18-month window, could expand the equity base, especially when a company has recently completed a large bonus allotment. In Bizotic Commercial’s case, the bonus allotment has already increased the share count from 96,42,000 to 5,78,52,000 and paid-up capital from Rs. 9.64 crore to Rs. 57.85 crore.

What to watch next

Bizotic Commercial has said the EGM notice and other relevant documents will be submitted in due course, indicating more disclosures are expected after the September 30 board meeting. The next key updates, based on the company’s stated agenda, would be the board-approved warrant issue price and the confirmed EGM schedule. Any preferential issue will remain subject to shareholder approval and other applicable approvals as stated by the company.